Bexagliflozin
id:
bexagliflozin-282-4809114
title:
Bexagliflozin
text:
Bexagliflozin, sold under the brand name Brenzavvy, is an antidiabetic medication used to improve glycemic control in adults with type 2 diabetes. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that is taken by mouth. The most common side effects include genital yeast infections, urinary tract infections, and increased urination. Bexagliflozin was approved for medical use in the United States in January 2023.
brand slug:
wiki
category slug:
encyclopedia
description:
Antidiabetic medication
original url:
https://en.wikipedia.org/wiki/Bexagliflozin
date created:
date modified:
2024-04-18T19:26:35Z
main entity:
{"identifier":"Q27277423","url":"https://www.wikidata.org/entity/Q27277423"}
image:
fields total:
13
integrity:
14